全文获取类型
收费全文 | 782篇 |
免费 | 94篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 69篇 |
妇产科学 | 15篇 |
基础医学 | 123篇 |
口腔科学 | 31篇 |
临床医学 | 79篇 |
内科学 | 169篇 |
皮肤病学 | 20篇 |
神经病学 | 27篇 |
特种医学 | 132篇 |
外科学 | 48篇 |
综合类 | 45篇 |
预防医学 | 40篇 |
眼科学 | 30篇 |
药学 | 25篇 |
肿瘤学 | 28篇 |
出版年
2020年 | 6篇 |
2019年 | 7篇 |
2018年 | 19篇 |
2017年 | 7篇 |
2016年 | 21篇 |
2015年 | 22篇 |
2014年 | 26篇 |
2013年 | 41篇 |
2012年 | 19篇 |
2011年 | 12篇 |
2010年 | 45篇 |
2009年 | 47篇 |
2008年 | 15篇 |
2007年 | 26篇 |
2006年 | 12篇 |
2005年 | 17篇 |
2004年 | 7篇 |
2003年 | 11篇 |
2002年 | 5篇 |
2001年 | 7篇 |
1999年 | 6篇 |
1998年 | 42篇 |
1997年 | 42篇 |
1996年 | 43篇 |
1995年 | 37篇 |
1994年 | 23篇 |
1993年 | 29篇 |
1992年 | 6篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 18篇 |
1988年 | 17篇 |
1987年 | 11篇 |
1986年 | 14篇 |
1985年 | 17篇 |
1984年 | 10篇 |
1983年 | 13篇 |
1982年 | 6篇 |
1981年 | 15篇 |
1980年 | 8篇 |
1978年 | 4篇 |
1977年 | 8篇 |
1976年 | 9篇 |
1959年 | 4篇 |
1958年 | 18篇 |
1957年 | 16篇 |
1956年 | 18篇 |
1955年 | 15篇 |
1954年 | 9篇 |
1948年 | 5篇 |
排序方式: 共有884条查询结果,搜索用时 15 毫秒
51.
52.
53.
GS Chopra PK Gupta AC Anand PP Varma V Nair Ramji Rai 《Medical Journal Armed Forces India》2005,61(3):234-237
Background
HBV DNA quantitation is used extensively world wide for the diagnosis and monitoring of treatment of Hepatitis B virus (HBV) infection. However, it has still to be popular in India. The aim of this study was to quantitate HBV – DNA by Real time – PCR method in Hepatitis B and in immuno-compromised patients, to compare the results with HBeAg detection and to monitor the response to therapy of chronic Hepatitis B patients to antivirals.Methods
Ninety one serum samples of Hepatitis group of patients (all HBsAg positive), 41 samples from immuno-compromised patients (all HBsAg negative) and 49 patients of Chronic Hepatitis B group (all HBsAg positive) were the subjects of this first ever study in Armed Forces. Twenty serum samples from healthy volunteers and non-hepatitis B patients served as negative controls. The amplification detection was carried out in a Rotor-Gene 2000-sequence detectorResults
Amongst Hepatitis B group, 33% (30/91) of the samples were positive for HBV-DNA and 26% (24/91) of samples were positive for HBeAg. In the immuno-compromised group of patients 14.6% (6/11) of samples were positive for HIV-DNA and 9.7% (4/41) were positive for HBeAg. Of the Chronic Hepatitis B patients on treatment, all (100%) were positive by HBV-DNA, whereas 29/49 (59.2%) were positive by HBeAg before treatment. After treatment with antivirals, 06/49 (12.2%) were positive by both tests and 11/49 (22.5%) were positive only by HBV-DNA. 32/49 (65.3%) patients became negative serologically after therapy.Conclusion
HBeAg status did not necessarily reflect HBV-DNA level in the serum, as 10/91 (11%) in the Hepatitis B group, 2/41 (4.9%) in the immuno compromised group and 20/49 (40.8%) patients in the Chronic Hepatitis B group were positive for HBV-DNA but negative for HBeAg. HBV-DNA was not found to be positive amongst any of the negative controls. Real time – PCR is a sensitive and reproducible assay for HBV-DNA quantitation and may be started in Armed Forces referral centers in the near future.Key Words: Real time – PCR, Chronic Hepatitis B, HBV – DNA, Antivirals 相似文献54.
LLOYD K. SHIELD RUSSELL G. WILKINSON MARGARET RITCHIE STANLEY KORMAN 《Journal of paediatrics and child health》1981,17(1):59-61
ABSTRACT. The syndrome of infant botulism was first recognised in late 1975 and the majority of cases reported have been from the United States of America. One case has been reported from the United Kingdom and one from Canada.
A three-month-old male infant from Victoria, Australia presented with constipation, marked hypotonia, limb weakness, ptosis, facial weakness and inability to suck and swallow. These abnormalities resolved and he returned to normal over the ensuing months.
A diagnosis of infant botulism was confirmed after the isolation of Clostridium botulinum type B from the faeces.
Infant botulism has now been recognised in four different countries and it is likely than with increasing awareness of this striking clinical syndrome, more cases will be identified. 相似文献
A three-month-old male infant from Victoria, Australia presented with constipation, marked hypotonia, limb weakness, ptosis, facial weakness and inability to suck and swallow. These abnormalities resolved and he returned to normal over the ensuing months.
A diagnosis of infant botulism was confirmed after the isolation of Clostridium botulinum type B from the faeces.
Infant botulism has now been recognised in four different countries and it is likely than with increasing awareness of this striking clinical syndrome, more cases will be identified. 相似文献
55.
Computed tomography of abdominal fatty masses 总被引:2,自引:0,他引:2
56.
57.
58.
59.
OBJECTIVE:
Inflammation plays an important role in the development of chronic lung disease (CLD), which has become a major cause of morbidity in surviving infants less than 1250 g at birth. The authors hypothesized that the progression of this inflammation and, therefore, the establishment of CLD would be decreased with the use of early prophylactic inhaled corticosteroids. Short, and long term respiratory and neurodevelopmental outcomes were also examined.DESIGN:
A double-blind, randomized placebo controlled trial.SETTING:
Level-III neonatal intensive care unit.POPULATION STUDIED:
Sixty infants less than 1250 g at birth, diagnosed with respiratory distress syndrome and requiring ventilatory support at 72 h of age were enrolled in the study.INTERVENTION:
Infants enrolled received either placebo or beclomethasone diproprionate by a metered dose inhaler, which was used in-line with the ventilator circuit while the infant was ventilated and then via a spacer until 28 days of age.RESULTS:
Thirty infants were given beclomethasone and 30 were given placebo. There were two deaths in each group. Among the surviving infants, the frequency of moderate-to-severe CLD was 17% in each study group. Mean time to extubation was not different for beclomethasone compared with placebo at 16.4 and 12.5 days (P=0.12), respectively. The requirement for intravenous corticosteroids was lower in the beclomethasone-treated group (RR 0.67, 95% CI 0.43 to 1.04), although this difference was not statistically significant. The incidence of growth failure, infection and intraventricular hemmorhage did not differ between the two groups. Long term outcomes were not different with respect to the incidence of respiratory re-admissions, cerebral palsy, developmental delay, blindness or deafness.CONCLUSIONS:
Early treatment with inhaled beclomethasone diproprionate did not reduce the incidence of CLD or decrease the duration of mechanical ventilation. The decrease in intravenous corticosteroid use was not statistically significant. Long term outcome was not affected. 相似文献60.
Ventral hernia repair: a study of current practice 总被引:5,自引:5,他引:0
Ventral wall hernias are common; despite this, there are no guidelines on the best surgical management. The aim of this study
was to examine the types of repair in use for abdominal wall hernias in the West of Scotland over a 3-month period. Data were
gathered on 120 patients. There were 60 incisional, 32 umbilical, and 28 epigastric hernias. The main indication for repair
was pain (78%), while 12 patients (10%), presented acutely with incarceration or strangulation. The most common method of
repair was sutured (55%), followed by mesh (29%) and Mayo repair (16%). There was no correlation between use of mesh and hernia
size or whether repair was for a recurrent hernia. Surgical practice varies widely in the repair of ventral wall hernias.
Clinical trials are required to establish the best method of repair for this common condition.
Electronic Publication 相似文献